Literature DB >> 32043910

Enhancing Cooperation Between Academic Biobanks and Biomedical Industry: Better Mutual Understanding and New Collaborative Models Are Needed.

Daniel Simeon-Dubach1, Michael H Roehrl2, Paul Hofman3, Pascal Puchois4.   

Abstract

Mesh：

Year:  2020        PMID： 32043910      PMCID： PMC7476386          DOI： 10.1089/bio.2019.0095

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN： 1947-5543            Impact factor:   2.300


× No keyword cloud information.
  28 in total

1.  Biobanking 3.0: evidence based and customer focused biobanking.

Authors:  Daniel Simeon-Dubach; Peter Watson
Journal:  Clin Biochem       Date:  2014-01-06       Impact factor: 3.281

Review 2.  Biobanking trends, challenges, and opportunities.

Authors:  Fiona Mackenzie
Journal:  Pathobiology       Date:  2015-03-16       Impact factor: 4.342

3.  Partnering with the professor.

Authors:  Beth Schachter
Journal:  Nat Biotechnol       Date:  2012-10       Impact factor: 54.908

4.  The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic.

Authors:  Anna D Barker; Carolyn C Compton; George Poste
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

5.  Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality Center.

Authors:  Patrick L Fitzgibbons; Linda A Bradley; Lisa A Fatheree; Randa Alsabeh; Regan S Fulton; Jeffrey D Goldsmith; Thomas S Haas; Rouzan G Karabakhtsian; Patti A Loykasek; Monna J Marolt; Steven S Shen; Anthony T Smith; Paul E Swanson
Journal:  Arch Pathol Lab Med       Date:  2014-03-19       Impact factor: 5.534

6.  Parsing clinical success rates.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2016-06-30       Impact factor: 84.694

Review 7.  Public-private relationships in biobanking: a still underestimated key component of open innovation.

Authors:  Paul Hofman; Christian Bréchot; Kurt Zatloukal; Georges Dagher; Bruno Clément
Journal:  Virchows Arch       Date:  2013-12-14       Impact factor: 4.064

8.  Broad Consent for Research on Biospecimens: The Views of Actual Donors at Four U.S. Medical Centers.

Authors:  Teddy D Warner; Carol J Weil; Christopher Andry; Howard B Degenholtz; Lisa Parker; Latarsha J Carithers; Michelle Feige; David Wendler; Rebecca D Pentz
Journal:  J Empir Res Hum Res Ethics       Date:  2018-02-01       Impact factor: 1.742

Review 9.  Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures.

Authors:  Scott E Kern
Journal:  Cancer Res       Date:  2012-11-19       Impact factor: 12.701

10.  Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.

Authors:  Thomas D'Hooghe
Journal:  Hum Reprod       Date:  2017-08-01       Impact factor: 6.918
View more
  3 in total

1.  Building Research Support Capacity across Human Health Biobanks during the COVID-19 Pandemic.

Authors:  Jennifer A Byrne; Jane E Carpenter; Candace Carter; Kathleen Phillips; Stephen Braye; Peter H Watson; Amanda Rush
Journal:  Biomark Insights       Date:  2021-06-14

Review 2.  Basic principles of biobanking: from biological samples to precision medicine for patients.

Authors:  Laura Annaratone; Giuseppe De Palma; Giuseppina Bonizzi; Anna Sapino; Gerardo Botti; Enrico Berrino; Chiara Mannelli; Pamela Arcella; Simona Di Martino; Agostino Steffan; Maria Grazia Daidone; Vincenzo Canzonieri; Barbara Parodi; Angelo Virgilio Paradiso; Massimo Barberis; Caterina Marchiò
Journal:  Virchows Arch       Date:  2021-07-13       Impact factor: 4.064

Review 3.  Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients.

Authors:  Paul Hofman
Journal:  Transl Lung Cancer Res       Date:  2020-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.